Latest Breaking News On - Lunresertib lunre - Page 1 : comparemela.com

Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating lunresertib in combination with FOLFIRI for the.

Lunresertib lunreZeva wainbergRepare therapeutics incEuropean society of medical oncologyGastrointestinal gi cancers congressCompany nasdaqDavid geffen school of medicineRepare therapeuticsEuropean societyMedical oncologyCancers congressAdvanced gastrointestinalDavid geffen school